Related Experiment Videos
Id proteins--tumor markers or oncogenes?
1Department of Pathology, Harvard Center for Cancer Biology, Harvard Medical School, 200 Longwood Avenue, Building D2, Room 544A, Boston, Massachusetts 02115-5701, USA.
Cancer Biology & Therapy
|August 13, 2002
Summary
Inhibitor of differentiation (Id) proteins block cell differentiation and promote proliferation, potentially acting as oncogenes in cancer. This review explores Id protein biology and their role in carcinogenesis.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Id (Inhibitor of differentiation or Inhibitor of DNA-binding) proteins are dominant negative regulators.
- They inhibit differentiation-specific basic Helix-Loop-Helix (bHLH) transcription factors.
- Id proteins modulate cell cycle regulators, promoting proliferation and inhibiting differentiation.
Purpose of the Study:
- To review the fundamental biology of Id proteins.
- To discuss the role of Id proteins in cellular differentiation and proliferation.
- To examine the implication of Id protein overexpression in various cancer types and their potential role as oncogenes.
Main Methods:
- Literature review of existing research on Id proteins.
- Analysis of Id protein mechanisms in regulating cell cycle and differentiation.
- Synthesis of data linking Id protein overexpression to carcinogenesis.
Main Results:
- Id proteins function as dominant negative regulators, suppressing differentiation.
- Ectopic Id expression leads to cellular immortalization and blocked differentiation.
- Overexpression of Id proteins is observed in multiple cancer types.
Conclusions:
- Id proteins play a critical role in regulating cell differentiation and proliferation.
- Their aberrant expression suggests a significant role in cancer development.
- Id proteins represent potential therapeutic targets as oncogenes in oncology.